Study of Oral Oteseconazole (VT-1161) for Acute Yeast Infections in Patients With Recurrent Yeast Infections

NCT03840616 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

219

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent Vulvovaginal Candidiasis

Interventions

DRUG: Oteseconazole (VT-1161) 150mg capsule
DRUG: Fluconazole 150mg capsule
DRUG: Placebo

Sponsor

Mycovia Pharmaceuticals Inc.